Owner Insert Therapeutics, Inc

Inventors Jensen, Gregory S; Pun, Suzie Hwang; Davis, Mark E

Agent Shelston IP

Pub. Number AU-B-2002368202

PCT Number PCT/US2002/0354

PCT Pub. Number WO2004/033620

Priority 60/336314 02.11.01 US; 60/337,304 05.11.01 US; 60/418,909 15.10.02 US

Filing date 4 November 2002

Wipo publication date 4 May 2004

Acceptance publication date 5 June 2008

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61K 47/40 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61L 27/00 (2006.01) Materials for prostheses or for coating prostheses

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates